Range
32.23 - 33.43
Vol / Avg.
1.2M/1.3M
Div / Yield
-
52 Wk
24.24 - 68.39
Mkt Cap
2.2B
Payout Ratio
-
Open
32.68
P/E
-
EPS
-3.01
Shares
67.4M
Outstanding
67.4M
Total Float
53.2M
load more
Sector: Health Care.Industry: Biotechnology
bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-04
REV
Q1 2021Est.ActualSurprise
EPS-3.010-3.070 -0.0600
REV11.370M12.794M1.424M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BLUEbluebird bio0.52%2.2B

bluebird bio Frequently Asked Questions

Q

How do I buy bluebird bio (BLUE) stock?

A

You can purchase shares of bluebird bio (NASDAQ: BLUE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are bluebird bio's (BLUE) competitors?

Q

What is the target price for bluebird bio (BLUE) stock?

A

The latest price target for bluebird bio (NASDAQ: BLUE) was reported by Morgan Stanley on April 19, 2021. The analyst firm set a price target for 36.00 expecting BLUE to rise to within 12 months (a possible 8.60% upside). 16 analyst firms have reported ratings in the last year.

Q

Current Stock Price for bluebird bio (BLUE)?

A

The stock price for bluebird bio (NASDAQ: BLUE) is $33.15 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does bluebird bio (BLUE) pay a dividend?

A

There are no upcoming dividends for bluebird bio.

Q

When is bluebird bio (NASDAQ:BLUE) reporting earnings?

A
bluebird bio’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is bluebird bio (BLUE) going to split?

A

There is no upcoming split for bluebird bio.

Q

What sector and industry does bluebird bio (BLUE) operate in?

A

bluebird bio is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.